申请人:TAISHO PHARMACEUTICAL CO., LTD
公开号:US20150175541A1
公开(公告)日:2015-06-25
There are provided compounds having a superior PHD2 inhibitory effect that are represented by general formula (I′):
(in the above-mentioned general formula (I′),
W, Y, R
2
, R
3
, R
4
, and Y
4
are as described hereinabove), or pharmaceutically acceptable salts thereof.
提供了一些化合物,具有优越的PHD2抑制作用,其通式表示为(I'):(在上述通式(I')中,W、Y、R2、R3、R4和Y4如上所述),或其药学上可接受的盐。